Latest News in the pharma Industry

All

KBI Biopharma expands services, including cell therapy manufacturing, through acquisition

KBI Biopharma expands services, including cell therapy manufacturing, through acquisition

2 Feb 2017

Acquisition provides fully equipped facilities for the development and manufacture of clinical stage cellular therapy products, including three ISO7 cGMP manufacturing suites, extensive flow cytometry and analytical infrastructure.

Read more 
Japan IP High Court rules in Lilly's favour on Alimta vitamin regimen patents

Japan IP High Court rules in Lilly's favour on Alimta vitamin regimen patents

2 Feb 2017

Patents could provide intellectual property protection for Alimta in Japan until June 2021.

Read more 
Merck gets the thumbs up in Europe for Keytruda to treat patients with metastatic NSCLC

Merck gets the thumbs up in Europe for Keytruda to treat patients with metastatic NSCLC

2 Feb 2017

First anti-PD-1 therapy approved in Europe for previously untreated patients with metastatic NSCLC.

Read more 
Aralez Pharmaceuticals unveils new office in Ireland

Aralez Pharmaceuticals unveils new office in Ireland

2 Feb 2017

The Dublin offices are the company's first permanent business premises outside of North America.

Read more 
EPO upholds decision regarding Sprycel

EPO upholds decision regarding Sprycel

1 Feb 2017

Patent found to be invalid.

Read more 
Allergan successfully completes LifeCell acquisition

Allergan successfully completes LifeCell acquisition

1 Feb 2017

Acquisition creates world-class aesthetic and regenerative medicine business in plastic surgery.

Read more 
Biogen completes separation of global hemophilia business, Bioverativ

Biogen completes separation of global hemophilia business, Bioverativ

1 Feb 2017

Bioverativ common stock to be traded on the NASDAQ global select market.

Read more 
Sanofi's Xyzal Allergy 24HR approved for OTC use in the US

Sanofi's Xyzal Allergy 24HR approved for OTC use in the US

1 Feb 2017

Xyzal is an oral antihistamine with a proven 24-hour effect.

Read more 
Kevzara receives first approval in Canada

Kevzara receives first approval in Canada

1 Feb 2017

Regulatory decisions for Kevzara are anticipated in the US and European Union later this year.

Read more 
Novartis' Votubia receives EU approval to treat refractory partial-onset seizures in patients with TSC

Novartis' Votubia receives EU approval to treat refractory partial-onset seizures in patients with TSC

31 Jan 2017

Decision marks the third TSC-related indication for Votubia in the EU.

Read more 
Mylan wins US District Court ruling related to Copaxone 40 mg/mL patents

Mylan wins US District Court ruling related to Copaxone 40 mg/mL patents

31 Jan 2017

Patents in question invalidated based on obviousness.

Read more 
IBA Molecular acquires Mallinckrodt nuclear imaging to create world-class radiopharmaceuticals group

IBA Molecular acquires Mallinckrodt nuclear imaging to create world-class radiopharmaceuticals group

31 Jan 2017

The enlarged business will comprise 21 manufacturing centres and commercial operations across 60 countries.

Read more